The Cross-Disease Biomarker Levelling Framework CDBLF — A Universal Patient-Level Prediction Formula Across Diseases, Fractal Levels, and Measurement Technologies

Read full text Summarise with VIRAT
Authors: Raimo van der Klein
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Clinical prediction models are built per disease, trained on many features, and do not transfer between conditions. This paper presents the Cross-Disease Biomarker Levelling Framework (CDBLF): a single formula — Meff = M × (1 − D) / (1 + D) — that predicts patient outcomes across five diseases in four organ systems using two measurements per patient and zero fitted parameters. Results across seven public datasets: AUC 0.808 in NSCLC (n=159), outperforming PD-L1 CPS (AUC 0.64), senior oncologist judgment (AUC 0.72), and the SCORPIO machine learning system trained on 9,745 patients (AUC 0.76). AUC 0.889 in melanoma (n=19). AUC 0.933 at the molecular level in basal cell carcinoma (n=11). AUC 0.853 in type 2 diabetes (n=367). AUC 0.763 in heart failure (n=299). All patient-level data is included. The formula requires no training, no machine learning, no software licence. Two measurements. One formula.

Fields of Study & Subjects

Artificial Intelligence in Healthcare Machine Learning in Healthcare Inflammatory Biomarkers in Disease Prognosis

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
22 March 2026
Language
EN
Document type
Preprint